Table 5 Actigraphy results, comparing CD severity groups and controls.
From: Self-reported sleep disturbance in Crohn’s disease is not confirmed by objective sleep measures
Crohn’s Disease (n = 61) | Control group (n = 60) | P | Crohn’s disease, remission (n = 27) | Crohn’s disease, active (n = 34) | P-value* | |
|---|---|---|---|---|---|---|
Total sleep time (min) | 405.8 | 415.8 | 0.15 | 408 | 403.9 | 0.93 |
Sleep efficiency | 91% | 91.50% | 0.64 | 92.20% | 90.10% | 0.19 |
Latency to persistent sleep (min) | 9 | 9 | 0.8 | 8.5 | 9.5 | 0.29 |
Total wake time during sleep (min) | 50 | 48.2 | 0.53 | 48.8 | 50.9 | 0.5 |
Numbers of wake episodes | 7.8 | 8.5 | 0.23 | 7.3 | 8.2 | 0.35 |
Longest sleep episode duration (min) | 209.1 | 213.1 | 0.8 | 222 | 197.9 | 0.34 |
Mean sleep episode duration (min) | 91.6 | 80.3 | 0.32 | 103.9 | 80.8 | 0.25 |
Percentage of subjects with normal total sleep time | 72.4% | 84.20% | 0.13 | 77.80% | 67.70% | 0.39 |
Percentage of subjects with normal sleep efficiency | 86.4% | 85.70% | 0.65 | 92.60% | 81.30% | 0.19 |
Percentage of subjects with abnormal wake time during sleep | 51.7% | 42.90% | 0.34 | 44.40% | 57.60% | 0.31 |
